ATE233321T1 - Verbesserungen in der herstellung von proteinen in wirtszellen - Google Patents

Verbesserungen in der herstellung von proteinen in wirtszellen

Info

Publication number
ATE233321T1
ATE233321T1 AT95929672T AT95929672T ATE233321T1 AT E233321 T1 ATE233321 T1 AT E233321T1 AT 95929672 T AT95929672 T AT 95929672T AT 95929672 T AT95929672 T AT 95929672T AT E233321 T1 ATE233321 T1 AT E233321T1
Authority
AT
Austria
Prior art keywords
pct
nucleic acid
production
sec
host cell
Prior art date
Application number
AT95929672T
Other languages
English (en)
Inventor
Julie Milland
Bruce Loveland
Dale Christiansen
Ian F C Mckenzie
Original Assignee
Austin Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Austin Research Inst filed Critical Austin Research Inst
Application granted granted Critical
Publication of ATE233321T1 publication Critical patent/ATE233321T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Reproductive Health (AREA)
  • Virology (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT95929672T 1994-08-30 1995-08-30 Verbesserungen in der herstellung von proteinen in wirtszellen ATE233321T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPM7724A AUPM772494A0 (en) 1994-08-30 1994-08-30 Improvements in production of proteins in host cells
PCT/AU1995/000553 WO1996006937A1 (en) 1994-08-30 1995-08-30 Improvements in production of proteins in host cells

Publications (1)

Publication Number Publication Date
ATE233321T1 true ATE233321T1 (de) 2003-03-15

Family

ID=3782245

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95929672T ATE233321T1 (de) 1994-08-30 1995-08-30 Verbesserungen in der herstellung von proteinen in wirtszellen

Country Status (9)

Country Link
US (1) US6130062A (de)
EP (1) EP0770137B1 (de)
JP (1) JPH10507625A (de)
AT (1) ATE233321T1 (de)
AU (1) AUPM772494A0 (de)
CA (1) CA2198345A1 (de)
DE (1) DE69529750D1 (de)
NZ (1) NZ291735A (de)
WO (1) WO1996006937A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6166288A (en) * 1995-09-27 2000-12-26 Nextran Inc. Method of producing transgenic animals for xenotransplantation expressing both an enzyme masking or reducing the level of the gal epitope and a complement inhibitor
EP1025244A2 (de) * 1997-10-20 2000-08-09 Genzyme Transgenics Corporation Neue modifizierte msp-1 nukleinsäuresequenzen und verfahren zur erhöhung der mrna-niveau und der proteinexpression in zellsystemen
US7598079B2 (en) * 1998-12-24 2009-10-06 Novation Pharmaceuticals, Inc. Assay for identifying compounds which affect stability of mRNA
CA2533259C (en) * 2003-07-21 2014-01-28 Lifecell Corporation Acellular tissue matrices made from galactose .alpha.-1,3-galactose-deficient tissue
WO2006113861A2 (en) * 2005-04-20 2006-10-26 Wyeth Mammalian expression systems
SG174013A1 (en) 2006-07-27 2011-09-29 Wyeth Corp High-cell density fed-batch fermentation process for producing recombinant protein
US9420770B2 (en) 2009-12-01 2016-08-23 Indiana University Research & Technology Corporation Methods of modulating thrombocytopenia and modified transgenic pigs
AU2011295715B9 (en) 2010-09-03 2017-02-23 Abbvie Stemcentrx Llc Novel modulators and methods of use
WO2015066668A1 (en) 2013-11-04 2015-05-07 Lifecell Corporation Methods of removing alpha-galactose

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3341089A (en) * 1988-03-11 1989-10-05 Upjohn Company, The Ribosome binding site
AU638438B2 (en) * 1989-02-24 1993-07-01 Monsanto Technology Llc Synthetic plant genes and method for preparation
AU6448990A (en) * 1989-09-29 1991-04-28 Her Majesty in Right of Canada, as represented by National Research Council Canada Synthesis of mature human parathyroid hormone
EP0537171B1 (de) * 1990-05-11 2002-09-18 The Austin Research Institute CD46 Isoformen
US6174666B1 (en) * 1992-03-27 2001-01-16 The United States Of America As Represented By The Department Of Health And Human Services Method of eliminating inhibitory/instability regions from mRNA

Also Published As

Publication number Publication date
EP0770137A4 (de) 1999-10-27
CA2198345A1 (en) 1996-03-07
EP0770137A1 (de) 1997-05-02
NZ291735A (en) 1998-02-26
WO1996006937A1 (en) 1996-03-07
EP0770137B1 (de) 2003-02-26
DE69529750D1 (de) 2003-04-03
US6130062A (en) 2000-10-10
JPH10507625A (ja) 1998-07-28
AUPM772494A0 (en) 1994-09-22

Similar Documents

Publication Publication Date Title
DE69018920D1 (de) Verwendung von dns-fragmenten, die ein signalpeptid kodieren zur sekretion von reifen proteinen in rekombinanten hefen, expressions-kassetten, transformierte hefen und verfahren zur herstellung dieser proteine.
FI852547L (fi) Framstaellning av faktor viii och daertill hoerande produkter.
BR8301918A (pt) Proteina,sequencia de dna,veiculo de expressao replicavel,microorganismo ou cultura celular,plasmideo,composicao,cultura de celulas,utilizacao de tal proteina,processo de expressao,processo para producao de um veiculo de expressao e processo para preparacao de uma proteina uroquinase
DE69534618D1 (de) Verfahren zur herstellung rekombinanter adeno-associated viren (aav) und deren verwendung
DE69934967D1 (de) Verfahren zur verminderung der immunogenität von proteinen
ATE312190T1 (de) Nukleinsaeure enthaltende zusammensetzungen, herstellung und verwendung
DE69131580D1 (de) GDF-1 und UOG1 Proteine
PT917571E (pt) Gene relacionado com agouti
DE3585953D1 (de) Dna-fragmente, expressionsvektoren, proteine, wirte und verfahren zur herstellung der proteine.
DE69939330D1 (de) Wachstumsfaktor-homologe zvegf-3
DK0851926T3 (da) Varianter af humant rekombinant gamminterferon (rhu-IFN-gamma) med forøget termisk stabilitet
DE69533102D1 (de) Analog von haemophilus hin47 mit verminderter protease aktivität
DE69529750D1 (de) Verbesserungen in der herstellung von proteinen in wirtszellen
PT84089A (en) Dna sequences coding for proteins having the biological activity of husi-type i inhibitors biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins
YU172185A (en) Process for obtaining monoclonic anti-bodies
KR880009991A (ko) 항혈액응고작용을 갖는 폴리펩티드
DE59712235D1 (de) Immunologisch aktive proteine von borrelia burgdorferi, dafür kodierende nukleinsäuren sowie deren verwendung in testkits und als impfstoffe
DE69734596D1 (de) "smoothened" proteine aus wirbeltieren
SE9602822D0 (sv) New receptor
ATE196165T1 (de) Methoden zur herstellung von protein c
EP0676413A3 (de) Interferon alpha/beta bindendes Protein, seine Herstellung und Anwendung.
DE69929683D1 (de) Antisense modulierung von lfa-3
DE58909261D1 (de) Ancrod-proteine, ihre herstellung und verwendung.
ATE250935T1 (de) Neuartige cytokine
SE9604439D0 (sv) New receptor

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties